Alterations in blood-brain barrier function and brain pathology by morphine in the Rat. neuroprotective effects of antioxidant H-290/51

Acta Neurochirurgica, Supplementum

Volumn , Issue 106, 2009, Pages 61-66

  Sharma, Hari Shanker ^a,b   Sjöquist, Per Ove ^c   Ali, Syed F ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

blood brain barrier; brain edema; glial fibrillary acidic protein; H 290 51; Morphine withdrawal; neuronal damage; neuroprotection; oxidative stress

Indexed keywords

ANTIOXIDANT; H 290/51; MORPHINE SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; GLIA CELL; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; WITHDRAWAL SYNDROME;

EID: 78649362783     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-98811-4_10     Document Type: Conference Paper

References (23)

1. Crapo JD (2003) Oxidative stress as an initiator of cytokine release and cell damage. Eur Respir J Suppl Sep; 44:4s-6s. Review
2. Elliott KAC, Jasper H (1949) Measurement of experimentally induced brain swelling and shrinkage. Am J Physiol 157:122-129
3. Gul H, Yildiz O, Dogrul A, Yesilyurt O, Isimer A (2000) The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain Dec 15; 89(1):39-45
4. Hook MA, Liu GT, Washburn SN, Ferguson AR, Bopp AC, Huie JR, Grau JW (2007) The impact of morphine after a spinal cord injury. Behav Brain Res 179(2):281-293
5. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci Aug 18; 24(33):7353-7365
6. Kiyatkin EA, Brown PL, Sharma HS (2007) Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci Sep; 26(5):1242-1253
7. Maier SF, Watkins LR (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci Aug 18; 24(33):7353-7365
8. Merrill JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci Aug; 19(8):331-338. Review
9. Pérez-Casanova A, Noel RJ Jr, Rivera-Amill V, Husain K, Kumar A (2007) Morphine-mediated deterioration of oxidative stress leads to rapid disease progression in SIV/SHIV-infected macaques. AIDS Res Hum Retroviruses Aug; 23(8):1004-1007
10. Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven, New York
11. Sharma HS (2004) Blood-brain and spinal cord barriers in stress. In: Sharma HS, Westman J (eds) The blood-spinal cord and brain barriers in health and disease. Elsevier Academic, San Diego, pp 231-298
12. Sharma HS (2007) Neurobiology of hyperthermia. Prog Brain Res 162:1-617
13. Sharma HS, Ali SF (2006) Alterations in blood-brain barrier function by morphine and methamphetamine. Ann N Y Acad Sci Aug 1074:198-224
14. Sharma HS, Johanson CE (2007) Blood-cerebrospinal fluid barrier in hyperthermia. Prog Brain Res 162:459-478. Review
15. Sharma HS, SjÖquist PO (2002) A new antioxidant compound H-290/51 modulates glutamate and GABA immunoreactivity in therat spinal cord following trauma. Amino Acids 23(1-3):261-272
16. Sharma HS, Westman J (2004) The blood-spinal cord and brain barriers in health and disease. Elsevier/Academic, San Diego, pp 1-617 (release date: Nov. 9, 2003)
17. Sharma HS, Duncan JA, Johanson CE (2006) Whole-body hyperthermia in the rat disrupts the blood-cerebrospinal fluid barrier and induces brain edema. Acta Neurochir Suppl 96:426-431
18. Sharma HS, Lundstedt T, Boman A, Lek P, Seifert E, Wiklund L, Ali SF (2006) A potent serotonin-modulating compound AP-267 attenuates morphine withdrawal-induced blood-brain barrier dysfunction in rats. Ann N Y Acad Sci Aug 1074:482-496
19. Sharma HS, Patnaik R, Ray AK, Dey PK (2004) Blood-central nervous system barriers in morphine dependence and withdrawal. In: Sharma HS, Westman J (eds) The blood-spinal cord and brain barriers in health and disease. Elsevier Academic, San Diego, pp 299-328
20. Sharma HS, Westman J, Nyberg F (1998) Pathophysiology of brain edema and cell changes following hyperthermic brain injury. Prog Brain Res 115:351-412. Review
21. Sharma HS, Westman J, Alm P, Sjöquist PO, Cervós-Navarro J, Nyberg F (1997) Involvement of nitric oxide in the pathophysiology of acute heat stress in the rat. Influence of a new antioxidant compound H-290/51. Ann N Y Acad Sci Mar 15; 813:581-590
22. Sharma HS, Sjöquist PO, Ali SF (2007) Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51. Curr Pharm Des 13(18):1903-1923. Review
23. Westerlund C, Ostlund-Lindqvist AM, Sainsbury M, Shertzer HG, Sjöquist PO (1996) Characterization of novel indenoindoles. Part I. Structure-activity relationships in different model systems of lipid peroxidation. Biochem Pharmacol May 17; 51(10):1397-1402